Development of recombinant human augmenter of liver regeneration (ALR) for treatment of liver diseases

Pao Yue-kong Library Electronic Theses Database

Development of recombinant human augmenter of liver regeneration (ALR) for treatment of liver diseases

 

Author: Chan, Chi-leong
Title: Development of recombinant human augmenter of liver regeneration (ALR) for treatment of liver diseases
Degree: M.Phil.
Year: 2006
Subject: Hong Kong Polytechnic University -- Dissertations.
Liver -- Regeneration.
Liver cells.
Liver -- Diseases -- Treatment.
Department: Dept. of Applied Biology and Chemical Technology
Pages: xii, 168 leaves : ill. ; 31 cm.
Language: English
InnoPac Record: http://library.polyu.edu.hk/record=b2233460
URI: http://theses.lib.polyu.edu.hk/handle/200/4834
Abstract: Augmenter of liver regeneration (ALR; Hepatopoietin) is a novel hepatotrophic growth factor that stimulates hepatocyte proliferation by two pathways. Human ALR (hALR) is a protein that consists of 125 amino acids and its gene has been mapped on chromosome 16 next to the Polycystic Kidney Disease gene (PKD1). ALR belongs to Ervlp/ALR protein family, whose members have essential functions in the biogenesis of mitochondria. ALR has also been identified as a FAD-linked sulfhydryl oxidase. As ALR has the ability to stimulate hepatocyte proliferation and protect the liver in a liver specific manner, it is a potential drug for liver diseases. In this project, we have successfully produced several polyhistidine-tagged hALR proteins in Escherichia coli expression system. This approach allows single-step affinity purification. The result demonstrated that addition of 12 histidines molecules to the C-terminus of ALR is the best design by which about 330 mg/L of hALR was obtained from 2-L fermentation culture with 95% purity. The in vitro specificity and biological activity of the modified hALR in promoting liver cell growth were found to be similar to those of hepatocyte growth-promoting factor (pHGF), a commercially available drug in China to treat liver failure. Moreover, the modified hALR protein also possesses the sulfhydryl oxidase activity. Recombinant hALR proteins are not very soluble and readily precipitated in phosphate buffer saline (PBS) or elution buffer. To overcome this problem, the ALR was buffer exchanged into a special solution. The solubility of protein was increased by 50 times from 0.02 mg/ml to 1 mg/ml. Another solution to increase its solubility in MilliQ water was to modify the protein with polyethylene glycol (PEG) to produce pegylated hALR. The pegylated protein was fully active in terms of biological activity and sulfhydryl oxidase activity. These data suggest that modified ALR proteins are effective in hepatocyte regeneration.

Files in this item

Files Size Format
b22334609.pdf 2.415Mb PDF
Copyright Undertaking
As a bona fide Library user, I declare that:
  1. I will abide by the rules and legal ordinances governing copyright regarding the use of the Database.
  2. I will use the Database for the purpose of my research or private study only and not for circulation or further reproduction or any other purpose.
  3. I agree to indemnify and hold the University harmless from and against any loss, damage, cost, liability or expenses arising from copyright infringement or unauthorized usage.
By downloading any item(s) listed above, you acknowledge that you have read and understood the copyright undertaking as stated above, and agree to be bound by all of its terms.

     

Quick Search

Browse

More Information